Edmund Dunn, Principal Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 1,207 shares at $4.04 ($5K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Open-market sale of $5k GLUE by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2026-01-05 | $16K | — | Filing → |
| GLUE | SELL | 2025-06-04 | $9K | — | Filing → |
| GLUE | SELL | 2024-07-09 | $6K | — | Filing → |